1. APhA supports changes in laws, regulations, and policies to permit DEA-registered and trained opioid treatment program clinicians and other providers the ability to prescribe methadone for opioid use disorder and refer patients for additional services as needed.

2. APhA supports changes in laws, regulations, and policies to permit community pharmacy dispensing of methadone for opioid use disorder and appropriate compensation for these services.

3. APhA supports partnerships and collaborations to increase patient access to opioid treatment programs (OTPs) and clinicians.

4. APhA advocates for interprofessional education on laws, regulations, and policies regarding office-based prescribing and community pharmacy dispensing of methadone in curricula, postgraduate training, and continuing professional development programs of all health professions.

Topic: Drug Abuse, Control And Education

(JAPhA 64(4);102117, July/August 2024)

1. APhA supports changes in laws, regulations, and policies to permit DEA-registered and trained opioid treatment program clinicians and other providers the ability to prescribe methadone for opioid use disorder and refer patients for additional services as needed.

2. APhA supports changes in laws, regulations, and policies to permit community pharmacy dispensing of methadone for opioid use disorder and appropriate compensation for these services.

3. APhA supports partnerships and collaborations to increase patient access to opioid treatment programs (OTPs) and clinicians.

4. APhA advocates for interprofessional education on laws, regulations, and policies regarding office-based prescribing and community pharmacy dispensing of methadone in curricula, postgraduate training, and continuing professional development programs of all health professions.

Topic: Education, Curriculum And Competence For Pharmacy

(JAPhA 64(4);102117, July/August 2024)

1. APhA supports changes in laws, regulations, and policies to permit DEA-registered and trained opioid treatment program clinicians and other providers the ability to prescribe methadone for opioid use disorder and refer patients for additional services as needed.

2. APhA supports changes in laws, regulations, and policies to permit community pharmacy dispensing of methadone for opioid use disorder and appropriate compensation for these services.

3. APhA supports partnerships and collaborations to increase patient access to opioid treatment programs (OTPs) and clinicians.

4. APhA advocates for interprofessional education on laws, regulations, and policies regarding office-based prescribing and community pharmacy dispensing of methadone in curricula, postgraduate training, and continuing professional development programs of all health professions.

Topic: Education, Curriculum And Competence For Pharmacy

(JAPhA 64(4);102117, July/August 2024)

1. APhA supports changes in laws, regulations, and policies to permit DEA-registered and trained opioid treatment program clinicians and other providers the ability to prescribe methadone for opioid use disorder and refer patients for additional services as needed.

2. APhA supports changes in laws, regulations, and policies to permit community pharmacy dispensing of methadone for opioid use disorder and appropriate compensation for these services.

3. APhA supports partnerships and collaborations to increase patient access to opioid treatment programs (OTPs) and clinicians.

4. APhA advocates for interprofessional education on laws, regulations, and policies regarding office-based prescribing and community pharmacy dispensing of methadone in curricula, postgraduate training, and continuing professional development programs of all health professions.

Topic: Education, Curriculum And Competence For Pharmacy

(JAPhA 64(4);102117, July/August 2024)

1. APhA supports changes in laws, regulations, and policies to permit DEA-registered and trained opioid treatment program clinicians and other providers the ability to prescribe methadone for opioid use disorder and refer patients for additional services as needed.

2. APhA supports changes in laws, regulations, and policies to permit community pharmacy dispensing of methadone for opioid use disorder and appropriate compensation for these services.

3. APhA supports partnerships and collaborations to increase patient access to opioid treatment programs (OTPs) and clinicians.

4. APhA advocates for interprofessional education on laws, regulations, and policies regarding office-based prescribing and community pharmacy dispensing of methadone in curricula, postgraduate training, and continuing professional development programs of all health professions.

Topic: Prescribing Authority

(JAPhA 64(4);102117, July/August 2024)